• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Summarizing data on survival, relapse, and chronic graft-versus-host disease after bone marrow transplantation: motivation for and description of new methods.

作者信息

Pepe M S, Longton G, Pettinger M, Mori M, Fisher L D, Storb R

机构信息

Fred Hutchinson Cancer Research Center, Seattle, Washington 98104.

出版信息

Br J Haematol. 1993 Apr;83(4):602-7. doi: 10.1111/j.1365-2141.1993.tb04697.x.

DOI:10.1111/j.1365-2141.1993.tb04697.x
PMID:8518176
Abstract

Kaplan-Meier curves are frequently used to summarize survival, relapse, and chronic graft-versus-host disease (GVHD) data in the bone marrow transplant setting. Some fundamental problems with the use of Kaplan-Meier curves for the summary of relapse and GVHD are described. Alternatively, the use of simple probability and conditional probability curves for summarizing relapse incidence and transplant-related mortality is illustrated with previously published data from a randomized clinical trial. Prevalence curves provide an appropriate alternative for the summary of a transient condition such as chronic GVHD. When combined with Kaplan-Meier curves for survival and/or relapse-free survival, these methods provide a more accurate and comprehensive summary of the various marrow transplant outcomes. These methods of display are also applicable to other settings where more than one type of treatment failure can occur and where follow-up time may be variable.

摘要

相似文献

1
Summarizing data on survival, relapse, and chronic graft-versus-host disease after bone marrow transplantation: motivation for and description of new methods.
Br J Haematol. 1993 Apr;83(4):602-7. doi: 10.1111/j.1365-2141.1993.tb04697.x.
2
Impact of cyclosporine and methylprednisolone dose used for prophylaxis and therapy of graft-versus-host disease on survival and relapse after allogeneic bone marrow transplantation.环孢素和甲泼尼龙用于预防和治疗移植物抗宿主病的剂量对异基因骨髓移植后生存和复发的影响。
Bone Marrow Transplant. 1999 Jan;23(2):145-50. doi: 10.1038/sj.bmt.1701529.
3
Improved graft-versus-host disease-free, relapse-free survival associated with bone marrow as the stem cell source in adults.在成人中,以骨髓作为干细胞来源可改善无移植物抗宿主病、无复发的生存率。
Haematologica. 2016 Jun;101(6):764-72. doi: 10.3324/haematol.2015.138990. Epub 2016 Apr 1.
4
Graft-versus-leukaemia activity associated with CMV-seropositive donor, post-transplant CMV infection, young donor age and chronic graft-versus-host disease in bone marrow allograft recipients. The Nordic Bone Marrow Transplantation Group.骨髓移植受者中,与巨细胞病毒血清学阳性供者、移植后巨细胞病毒感染、供者年龄小以及慢性移植物抗宿主病相关的移植物抗白血病活性。北欧骨髓移植组。
Bone Marrow Transplant. 1990 Jun;5(6):413-8.
5
Long-term outcomes after standard graft-versus-host disease prophylaxis with or without anti-human-T-lymphocyte immunoglobulin in haemopoietic cell transplantation from matched unrelated donors: final results of a randomised controlled trial.在接受来自匹配无关供者的造血细胞移植时,使用或不使用抗人T淋巴细胞免疫球蛋白进行标准移植物抗宿主病预防后的长期结局:一项随机对照试验的最终结果
Lancet Haematol. 2017 Jun;4(6):e293-e301. doi: 10.1016/S2352-3026(17)30081-9.
6
Comparable composite endpoints after HLA-matched and HLA-haploidentical transplantation with post-transplantation cyclophosphamide.接受移植后环磷酰胺治疗的HLA匹配和HLA单倍型相同移植后的可比复合终点。
Haematologica. 2017 Feb;102(2):391-400. doi: 10.3324/haematol.2016.144139. Epub 2016 Oct 20.
7
Treatment of adult acute lymphoblastic leukemia with allogeneic bone marrow transplantation. Multivariate analysis of factors affecting acute graft-versus-host disease, relapse, and relapse-free survival.异基因骨髓移植治疗成人急性淋巴细胞白血病。影响急性移植物抗宿主病、复发及无复发生存的多因素分析。
Bone Marrow Transplant. 1991 Jun;7(6):453-9.
8
Distinct patterns of minimal residual disease associated with graft-versus-host disease after allogeneic bone marrow transplantation for chronic myelogenous leukemia.慢性粒细胞白血病异基因骨髓移植后与移植物抗宿主病相关的微小残留病的不同模式。
J Clin Oncol. 1995 Jul;13(7):1704-13. doi: 10.1200/JCO.1995.13.7.1704.
9
Comparison of graft-versus-host disease-free, relapse-free survival according to a variety of graft sources: antithymocyte globulin and single cord blood provide favorable outcomes in some subgroups.根据多种移植物来源对无移植物抗宿主病、无复发生存率进行比较:抗胸腺细胞球蛋白和单份脐血在某些亚组中提供了良好的结果。
Haematologica. 2016 Dec;101(12):1592-1602. doi: 10.3324/haematol.2016.149427. Epub 2016 Aug 4.
10
Omission of day 11 methotrexate does not appear to influence the incidence of moderate to severe acute graft-versus-host disease, chronic graft-versus-host disease, relapse rate or survival after HLA-identical sibling bone marrow transplantation.在 HLA 全相合同胞骨髓移植后,省略第 11 天的甲氨蝶呤似乎不会影响中重度急性移植物抗宿主病、慢性移植物抗宿主病的发生率、复发率或生存率。
Bone Marrow Transplant. 1995 Dec;16(6):755-8.

引用本文的文献

1
A Brief Introduction to Competing Risks in the Context of Kidney Disease Epidemiology.肾脏病流行病学背景下的竞争风险简介
Kidney360. 2022 Feb 17;3(4):740-743. doi: 10.34067/KID.0007382021. eCollection 2022 Apr 28.
2
Up-front rituximab maintenance improves outcome in patients with follicular lymphoma: a collaborative Nordic study. upfront 利妥昔单抗维持治疗可改善滤泡性淋巴瘤患者的预后:一项北欧协作研究。
Blood Adv. 2018 Jul 10;2(13):1562-1571. doi: 10.1182/bloodadvances.2018017673.
3
Zoledronic acid boosts γδ T-cell activity in children receiving αβ T and CD19 cell-depleted grafts from an HLA-haplo-identical donor.
唑来膦酸可增强接受来自HLA单倍型相合供体的αβ T细胞和CD19细胞去除移植物的儿童的γδ T细胞活性。
Oncoimmunology. 2016 Sep 27;6(2):e1216291. doi: 10.1080/2162402X.2016.1216291. eCollection 2017.
4
Five-year follow-up of patients with advanced chronic lymphocytic leukemia treated with allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning.非清髓性预处理后接受异基因造血细胞移植治疗的晚期慢性淋巴细胞白血病患者的五年随访
J Clin Oncol. 2008 Oct 20;26(30):4912-20. doi: 10.1200/JCO.2007.15.4757. Epub 2008 Sep 15.
5
Influence of T-cell depletion on chronic graft-versus-host disease: results of a multicenter randomized trial in unrelated marrow donor transplantation.T细胞清除对慢性移植物抗宿主病的影响:一项无关供体骨髓移植多中心随机试验的结果
Blood. 2005 Nov 1;106(9):3308-13. doi: 10.1182/blood-2005-04-1614. Epub 2005 Jul 26.
6
Allogeneic hematopoietic cell transplantation for infants with acute lymphoblastic leukemia.急性淋巴细胞白血病婴儿的异基因造血细胞移植
Blood. 2005 May 1;105(9):3749-56. doi: 10.1182/blood-2004-08-3312. Epub 2005 Jan 6.